BAILARD, INC.
Q1 2014 13F-HR Holdings
Net value change ($000)
+10,263
(1.7%)
New positions
41
Sold out positions
50
Turnover %
8.3%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| IYR | 55,606 | 5073.5% |
| LQD | 55,210 | 11176.1% |
| SPDR SERIES TRUST | 7,694 | 29.1% |
| PHYS | 2,885 | NEW |
| VLO | 2,210 | NEW |
| ENDOCYTE INC | 2,056 | 350.3% |
| MPC | 1,758 | NEW |
| FLEX | 1,742 | NEW |
| VTI | 1,482 | 3.4% |
| BIODELIVERY SCIENCES INTERNATIONAL INC | 1,457 | 101.7% |
Top Reduces (Value $000, Stocks/ETFs)
| EFA | -56,472 | -93.3% |
| IWN | -54,324 | -95.8% |
| XENOPORT INC | -4,297 | -87.4% |
| GLD | -2,621 | -72.0% |
| GNRC | -2,065 | -100.0% |
| VCA INC COM | -1,815 | -100.0% |
| GME | -1,571 | -100.0% |
| LORILLARD INC COM | -1,547 | -100.0% |
| SYNERGY PHARMACEUTICALS DEL | -1,304 | -68.0% |
| LUMOS PHARMA, INC. | -1,012 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|